Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
Phase 3 Study of Combination of Mitiglinide and Metformin in Patients With Type 2 Diabetes Mellitus
Sponsor: Chonbuk National University
A PHASE3 clinical study on Type 2 Diabetes, this trial is completed. The trial is conducted by Chonbuk National University and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Feb 2020 [monthly]
Completed PHASE3
First recorded
Aug 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chonbuk National University
- Chonnam National University
- Chungnam National University
- Eulji University
- Hallym University
- Korea University
- Kyungpook National University Hospital
- Pusan National University College of Medicine
- Seoul National University Hospital
- Seoul St. Mary's Hospital
- Sungkyunkwan University
- The Catholic University of Korea
- Uijeongbu St. Mary Hospital
- Yonsei University
For direct contact, visit the study record on ClinicalTrials.gov .